Andreas Börjesson's competencies
Practice Area | Jurisdiction | Rank | Agg. Deals Value | Clients Dimension | N. of Transactions | Last Quarter |
---|---|---|---|---|---|---|
Corporate M&A | SWEDEN | 133 | 35 | 25 | 7 | ![]() |
Equity Capital Markets | SWEDEN | 102 | 10 | 50 | 2 | ![]() |
Practice Area | Jurisdiction | Rank | Agg. Deals Value | Clients Dimension | N. of Transactions | Last Quarter |
Showing 1 to 2 of 2 entries
Client Reviews
The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessmentCommunication Skills
Technical skills
Efficiency
Effectiveness
Perceived Added Value
Ranking 2022: Andreas Börjesson - Synch Advokat
Ranking 2021: Andreas Börjesson - Synch Advokat
Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
---|---|---|---|---|
Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Ranking 2020: Andreas Börjesson - Synch Advokat
Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
---|---|---|---|---|
Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Significant Clients
The chart shows a balanced list of the Andreas Börjesson's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve MounthsTeam
The chart shows a balanced list of counselor working with Andreas Börjesson - based on PBV Monitor's analyzed transactions during last Twelve MounthsCo-Counsel
The Chart shows a balanced list of Andreas Börjesson's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve MounthsCounterparts
The Chart shows a balanced list of Andreas Börjesson's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve MounthsPeer Reviews
The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessmentRecent experiences
Gesynta Pharma's Investment Round1/29/2025
PolarVentures' Investment in Veat9/12/2024
Triboron's Private Placement 8/10/2024
Tandem Health's Investment Round7/26/2024